Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyStem Cell TransplantationCyclophosphamideLymphomaLymphoma, Non-HodgkinTreatment OutcomeStem CellsLymphoma, B-CellLymphoma, Mantle-CellAntineoplastic AgentsSalvage TherapyMelphalanMultiple MyelomaLymphoma, Large B-Cell, DiffuseLymphoma, T-CellLymphoma, FollicularHodgkin DiseaseEtoposideChemotherapy, AdjuvantDisease-Free SurvivalLymphoma, T-Cell, PeripheralRemission InductionHematopoietic Stem CellsVincristineDoxorubicinTransplantation ConditioningCytarabineThiotepaHematopoietic Stem Cell MobilizationCarmustineSurvival RateRecurrenceLymphoma, Large-Cell, AnaplasticBone Marrow PurgingAntibodies, Monoclonal, Murine-DerivedSurvival AnalysisPrognosisDose-Response Relationship, DrugBoronic AcidsEmbryonic Stem CellsPyrazinesDexamethasoneAmyloidosisMyeloablative AgonistsBurkitt LymphomaAdult Stem CellsCell DifferentiationBone Marrow TransplantationIfosfamidePrednisoneTime FactorsFlow CytometryAntibodies, MonoclonalLymphoma, T-Cell, CutaneousFollow-Up StudiesLymphoma, B-Cell, Marginal ZoneAntineoplastic Agents, AlkylatingThalidomideAntigens, CD34Transplantation, HomologousRetrospective StudiesLymphoma, AIDS-RelatedInduction ChemotherapyGranulocyte Colony-Stimulating FactorPluripotent Stem CellsWhole-Body IrradiationCisplatinLeukapheresisMesenchymal Stem Cell TransplantationDrug Administration ScheduleCells, CulturedPodophyllotoxinAutograftsStem Cell NicheMitoxantroneMesenchymal Stromal CellsNeoplasm StagingCarboplatinCell ProliferationBone MarrowImmunophenotypingB-LymphocytesNeural Stem CellsInduced Pluripotent Stem CellsBusulfanTranslocation, GeneticNeoplasm Recurrence, LocalMaintenance ChemotherapyAntigens, CDNeoplasm, ResidualBreast NeoplasmsT-Lymphocyte SubsetsAntigens, CD20NeoplasmsEnteropathy-Associated T-Cell LymphomaMethotrexate